Regular article
Interaction of benzimidazole anthelmintics with Haemonchus contortus tubulin: Binding affinity and anthelmintic efficacy

https://doi.org/10.1016/0014-4894(91)90023-PGet rights and content

Abstract

The ability of various benzimidazoles (BZs) to bind tubulin under different conditions was assessed by determining their IC50 values (the concentration of unlabeled drug required to inhibit 50% of the labeled drug binding), Ka (the apparent equilibrium association constant) and Bmax (the maximum binding at infinite [BZ]= [drugreceptor]). The ability of unlabeled benzimidazoles—fenbendazole, mebendazole (MBZ), oxibendazole (OBZ), albendazole (ABZ), rycobendazole (albendazole sulfoxide, ABZSO), albendazole sulfone, oxfendazole (OFZ), and thiabendazole—to bind tubulin was determined from their ability to inhibit the binding of [3H]MBZ or [3H]OBZ to tubulin in supernatants derived from unembryonated eggs or adult worms of Haemonchus contortus. The binding constants (IC50, Ka, and Bmax) correlated with the known anthelmintic potency (recommended therapeutic doses) of the BZ compounds except for OFZ and ABZSO whose Ka values were lower than could be expected from anthelmintic potency. The binding of [3H]ABZ or [3H]OFZ to tubulin in supernatants derived from BZ-susceptible and BZresistant H. contortus was compared. [3H]ABZ demonstrated saturable high-affinity binding but [3H]OFZ bound with low affinity. The high-affinity binding of [3H]ABZ was reduced for the R strain. Tubulin bound BZ drugs at 4 °C with lower apparent Ka than at 37 °C.

References (32)

  • G.W. Lubega et al.

    Specific interaction of benzimidazole anthelmintics with tubulin: High affinity binding and benzimidazole resistance in Haemonchus contortus

    Molecular and Biochemical Parasitology

    (1990)
  • G.W. Lubega et al.

    Specific interaction of benzimidazole anthelmintics with tubulin: Comparison of developing stages of thiabendazole-susceptible and thiabendazole-resistant strains of Haemonchus contortus

    Biochemical Pharmacology

    (1991)
  • E.B. Rapson et al.

    Trichostrongylus colubriformis, in vitro culture of parasite stages and their use for evaluation of anthelmintics

    Research in Veterinary Science

    (1985)
  • J.P. Bennett et al.

    Neurotransmitter, hormone or drug receptor binding models

  • J.H. Boersema

    Possibilities and limitations in the detection of anthelmintic resistance

  • M. Borgers et al.

    Ultrastructural changes in Ascaris suum intestine after mebendazole treatment in vivo

    Journal of Parasitology

    (1975)
  • Cited by (123)

    • Pharmacologic interaction between oxfendazole and triclabendazole: In vitro biotransformation and systemic exposure in sheep

      2019, Experimental Parasitology
      Citation Excerpt :

      In the present study, only OFZ MRT was significantly altered (roughly 16% increased) upon coadministration. In spite of exhibiting lesser potency than the parent compound, attributed to a lower affinity for helminth tubulin (Lubega and Prichard, 1991), OFZ does show anthelmintic activity. For this reason, altered OFZ PK parameters associated with coadministration with TCBZ could affect clinical efficacy.

    • Oxidative transformation kinetics and pathways of albendazole from reactions with manganese dioxide

      2018, Journal of Hazardous Materials
      Citation Excerpt :

      However, no further biological oxidized product (i.e. ABZ-SO2 with two oxygens added on the sulfur atom) was observed. ABZ-SO2 has been suggested to possess lower bio-toxicity than ABZ and ABZ-SO [13]. Unfortunately, MnO2 may not have enough oxidative power to further oxidize ABZ-SO.

    • A pharmacology-based comparison of the activity of albendazole and flubendazole against Echinococcus granulosus metacestode in sheep

      2013, Acta Tropica
      Citation Excerpt :

      In the case of ABZ, two metabolites are found in the systemic circulation after its administration to different animal species, ABZ-sulphoxide (ABZSO) and ABZ-sulphone (ABZSO2) (Marriner and Bogan, 1980; Prichard et al., 1985; Alvarez et al., 1995; Sánchez et al., 2000). While ABZSO is an active metabolite, ABZSO2 is not used as an anthelmintic and is probably inactive in vivo (Lubega and Prichard, 1999). However, most studies on ABZSO2 activity have been carried out in nematodes; its potential activity against other helminths, including cestodes and trematodes, is unknown.

    View all citing articles on Scopus
    View full text